GOSPEL: Prospective survey of gout in France. Part I: Design and patient characteristics (n=1003)

Joint Bone Spine

Volumn 79, Issue 5, 2012, Pages 464-470

  Lioté, Frédéric ^a,b,c,d   Lancrenon, Sylvie ^e   Lanz, Sabine ^f   Guggenbuhl, Pascal ^g   Lambert, Charles ^h   Saraux, Alain ⁱ   Chiarelli, Pierre ^j   Delva, Catherine ^e   Aubert, Jean Pierre ^a,b   Ea, Hang Korng ^a,b,c,d  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b Nancy Laboratoire de Physiologie   (France)

^c HÔPITAL LARIBOISIÈRE   (France)

^d CENTRE VIGGO PETERSEN   (France)

^e Sylia Stat   (France)

^f Laboratoires Galéniques Vernin   (France)

^g UNIVERSITÉ DE RENNES 1   (France)

^h IPSEN   (France)

ⁱ UNIVERSITÉ DE BRETAGNE OCCIDENTALE   (France)

^j Vivactis Études Cliniques   (France)

more..

Author keywords

Chronic kidney disease; Cohort; Diagnosis; Gout; Management; Metabolic syndrome; Obesity

Indexed keywords

DIURETIC AGENT;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CHRONIC KIDNEY DISEASE; CLINICAL FEATURE; COMORBIDITY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEMOGRAPHY; DESCRIPTIVE RESEARCH; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE EXACERBATION; DISEASE SEVERITY; DYSLIPIDEMIA; FEMALE; FOLLOW UP; FRANCE; GENERAL PRACTITIONER; GOUT; HEALTH SURVEY; HUMAN; HYPERGLYCEMIA; HYPERTENSION; HYPERURICEMIA; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; OBESITY; PHYSICIAN; RHEUMATOLOGY; SELF QUESTIONNAIRE; SEX RATIO; STRUCTURED QUESTIONNAIRE; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; COHORT STUDIES; COMORBIDITY; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; DISEASE MANAGEMENT; DYSLIPIDEMIAS; FEMALE; FRANCE; GOUT; HUMANS; HYPERTENSION; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PROSPECTIVE STUDIES; QUESTIONNAIRES; RESEARCH DESIGN;

EID: 84867998973     PISSN: 1297319X     EISSN: 17787254     Source Type: Journal    
DOI: 10.1016/j.jbspin.2011.12.006     Document Type: Article

References (30)

1. Smith E.U., Diaz-Torne C., Perez-Ruiz F., et al. Epidemiology of gout: an update. Best Pract Res Clin Rheumatol 2010, 24:811-827.
2. Terkeltaub R., Zelman D., Scavulli J., et al. Gout study group: update on hyperuricemia and gout. Joint Bone Spine 2009, 76:444-446.
3. Zhu Y., Pandya B.J., Choi H.K. Prevalence of gout and hyperuricemia in the US general population. Arthritis Rheum 2011, 63:3136-3141.
4. Xiang Y.J., Dai S.M. Prevalence of rheumatic diseases and disability in China. Rheumatol Int 2009, 29:481-490.
5. Chuang S.Y., Lee S.C., Hsieh Y.T., et al. Trends in hyperuricemia and gout prevalence: nd Health Survey in Taiwan from 1993-1996 to 2005-2008. Asia Pac J Clin Nutr 2011, 20:301-308.
6. Klemp P., Stansfield S.A., Castle B., et al. Gout is on the increase in New Zealand. Ann Rheum Dis 1997, 56:22-26.
7. Merriman T.R., Dalbeth N. The genetic basis of hyperuricaemia and gout. Joint Bone Spine 2011, 78:35-40.
8. Keenan R.T., O'Brien W.R., Lee K.H., et al. Prevalence of contraindications and prescription of pharmacologic therapies for gout. Am J Med 2011, 124:155-163.
9. Pillinger M.H., Goldfarb D.S., Keenan R.T. Gout and its comorbidities. Bull NYU Hosp Jt Dis 2010, 68:199-203.
10. van den Bussche H., Koller D., Kolonko T., et al. Which chronic diseases and disease combinations are specific to multimorbidity in the elderly? Results of a claims databased cross-sectional study in Germany. BMC Public Health 2011, 11:101.
11. O'Reilly S., Doherty M. Missed opportunity following diagnosis of gout. Ann Rheum Dis 1995, 54:86-87.
12. Pascual E., Sivera F. Why is gout so poorly managed?. Ann Rheum Dis 2007, 66:1269-1270.
13. Medellin M.V., Erickson A.R., Enzenauer R.J. Variability of treatment for gouty arthritis between rheumatologists and primary care physicians. J Clin Rheumatol 1997, 3:24-27.
14. Zhang W., Doherty M., Bardin T., et al. EULAR evidence based recommendations for gout. Part II: management. Report of a task force of the EULAR Standing Committee for International Clinical Studies including therapeutics (ESCISIT). Ann Rheum Dis 2006, 65:1312-1324.
15. Zhang W., Doherty M., Pascual E., et al. EULAR evidence based recommendations for gout. Part I: diagnosis. Report of a task force of the Standing Committee for International clinical studies including therapeutics (ESCISIT). Ann Rheum Dis 2006, 65:1301-1311.
16. Jordan K.M., Cameron J.S., Snaith M., et al. British Society for rheumatology and British Health Professionals in rheumatology guideline for the management of gout. Rheumatology (Oxford) 2007, 46:1372-1374.
17. Owens D., Whelan B., McCarthy G. A survey of the management of gout in primary care. Ir Med J 2008, 101:147-149.
18. Perez Ruiz F. Treatment of gout: reflections from the GEMA study. Reumatol Clin 2008, 4S2:41-44.
19. Roddy E., Zhang W., Doherty M. Concordance of the management of chronic gout in a UK primary-care population with the EULAR gout recommendations. Ann Rheum Dis 2007, 66:1311-1315.
20. Lioté F., Nguyen C. Goutte: critères de diagnostic, de classification et de qualité de vie. Rev Rhum Monographies 2010, 77:144-147.
21. Wallace S.L., Robinson H., Masi A.T., et al. Preliminary criteria for the classification of the acute arthritis of primary gout. Arthritis Rheum 1977, 20:895-900.
22. Alberti K.G., Zimmet P., Shaw J. Metabolic syndrome-a new world-wide definition. A consensus statement from the International Diabetes Federation. Diabet Med 2006, 23:469-480.
23. Harris M.D., Siegel L.B., Alloway J.A. Gout and hyperuricemia. Am Fam Physician 1999, 59:925-934.
24. Roddy E., Doherty M. Epidemiology of gout. Arthritis Res Ther 2010, 12:223.
25. Barber C., Thompson K., Hanly J.G. Impact of a rheumatology consultation service on the diagnostic accuracy and management of gout in hospitalized patients. J Rheumatol 2009, 36:1699-1704.
26. Harrold L.R., Saag K.G., Yood R.A., et al. Validity of gout diagnoses in administrative data. Arthritis Rheum 2007, 57:103-108.
27. Malik A., Schumacher H.R., Dinnella J.E., et al. Clinical diagnostic criteria for gout: comparison with the gold standard of synovial fluid crystal analysis. J Clin Rheumatol 2009, 15:22-24.
28. Janssens H.J., Fransen J., van de Lisdonk E.H., et al. A diagnostic rule for acute gouty arthritis in primary care without joint fluid analysis. Arch Intern Med 2010, 170:1120-1126.
29. Annemans L., Spaepen E., Gaskin M., et al. Gout in the UK and Germany: prevalence, comorbidities and management in general practice 2000-2005. Ann Rheum Dis 2008, 67:960-966.
30. Molto A., Olivé A. Anti-IL-1 molecules: new comers and new indications. Joint Bone Spine 2010, 77:102-107.